agilon health (AGL) Stock

agilon health, inc. (NYSE:AGL ) Q3 2024 Earnings Call Transcript November 7, 2024 4:30 PM ET Company Participants Leland Thomas - Senior Manager-Investor Relations Steven Sell - Chief Executive Officer Jeffrey Schwaneke - Chief Financial Officer Conference Call Participants Lisa Gill - JPMorgan Justin Lake - Wolfe Research Adam Ron - Bank of America George Hill - Deutsche Bank Sameer Patel - Evercore Ryan Langston - TD Cowen Stephen Baxter - Wells Fargo Andrew Mok - Barclays Jack Slevin - Jefferies Michael Ha - Baird Thomas Keller - RBC Daniel Grosslight - Citi Operator Good afternoon and thank you for joining the agilon health Third Quarter 2024 Earnings Conference Call.

I initially rated agilon health, inc. as a “hold” due to its volatile financial results and uncertain future, but recent developments necessitate a downgrade to 'sell'. The company's stock plummeted 60.1% since my last article, driven by disappointing Q3 results and reduced guidance, despite revenue growth. Rising medical costs and expansion expenses have severely impacted profitability, with a significant increase in net loss and negative EBITDA.

Agilon Health (AGL) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.10. This compares to loss of $0.06 per share a year ago.

agilon hagilon healthealth shares dropped significantly after disappointing financial results, down 11.9% in two days. The company's revenue surged 38.7% year over year, but its net loss nearly doubled, and guidance for 2024 is mixed. Concerns include declining cash reserves, potential for further dilution, and uncertainty regarding share valuation.

AGL Energy Limited (OTCPK:AGLNF) Q4 2024 Earnings Conference Call August 13, 2024 9:00 PM ET Company Participants Damien Nicks - Managing Director and Chief Executive Officer Gary Brown - Chief Financial Officer Markus Brokhof - Chief Operating Officer Jo Egan - Chief Customer Officer Conference Call Participants Tom Allen - UBS Anthony Moulder - Jefferies Dale Koenders - Barrenjoey Reinhardt van der Walt - Bank of America Merrill Lynch Mark Busuttil - JPMorgan Ian Myles - Macquarie Gordon Ramsay - RBC Capital Markets Rob Koh - Morgan Stanley Nik Burns - Jarden Australia Henry Meyer - Goldman Sachs Australia Operator Thank you for standing by and welcome to the AGL Energy Full-Year Results Briefing Conference Call. All participants will be in a listen-only mode.

While the top- and bottom-line numbers for Agilon (AGL) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Agilon Health (AGL) came out with a quarterly loss of $0.07 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.04 per share a year ago.

Investors can contact the law firm at no cost to learn more about recovering their losses.

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will participate in the 44th Annual William Blair Growth Stock Conference including a presentation on Wednesday, June 5, at 12:20 PM Eastern Time. A simultaneous webcast for the event can be accessed by visiting the “Events & Presentations” section of agilon's Investor Relations website at https://investors.agilonhealth.com.